Your browser doesn't support javascript.
loading
Author Correction: Fatty acid synthesis is required for breast cancer brain metastasis.
Ferraro, Gino B; Ali, Ahmed; Luengo, Alba; Kodack, David P; Deik, Amy; Abbott, Keene L; Bezwada, Divya; Blanc, Landry; Prideaux, Brendan; Jin, Xin; Posada, Jessica M; Chen, Jiang; Chin, Christopher R; Amoozgar, Zohreh; Ferreira, Raphael; Chen, Ivy X; Naxerova, Kamila; Ng, Christopher; Westermark, Anna M; Duquette, Mark; Roberge, Sylvie; Lindeman, Neal I; Lyssiotis, Costas A; Nielsen, Jens; Housman, David E; Duda, Dan G; Brachtel, Elena; Golub, Todd R; Cantley, Lewis C; Asara, John M; Davidson, Shawn M; Fukumura, Dai; Dartois, Véronique A; Clish, Clary B; Jain, Rakesh K; Vander Heiden, Matthew G.
Afiliação
  • Ferraro GB; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Ali A; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Luengo A; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.
  • Kodack DP; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Deik A; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Abbott KL; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Bezwada D; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Blanc L; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.
  • Prideaux B; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Jin X; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Posada JM; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Chen J; The Public Health Research Institute, New Jersey Medical School, Rutgers University, Newark, NJ, USA.
  • Chin CR; Institut de Chimie & Biologie des Membranes & des Nano-objets, CNRS UMR 5248, Bordeaux, France.
  • Amoozgar Z; The Public Health Research Institute, New Jersey Medical School, Rutgers University, Newark, NJ, USA.
  • Ferreira R; Department of Neuroscience, Cell Biology, and Anatomy, University of Texas Medical Branch, Galveston, TX, USA.
  • Chen IX; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.
  • Naxerova K; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Ng C; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Westermark AM; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Duquette M; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Roberge S; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Lindeman NI; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Lyssiotis CA; Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.
  • Nielsen J; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Housman DE; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Duda DG; Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Brachtel E; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Golub TR; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Cantley LC; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Asara JM; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Davidson SM; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Fukumura D; Division of Signal Transduction, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Dartois VA; University of Michigan, Ann Arbor, MI, USA.
  • Clish CB; Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.
  • Jain RK; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Vander Heiden MG; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
Nat Cancer ; 2(11): 1243, 2021 11.
Article em En | MEDLINE | ID: mdl-35122065
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article